Perigon Wealth Management’s Zimmer Biomet ZBH Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2026
Q1
$275K Buy
3,044
+739
+32% +$67.8K 0.01% 1056
2025
Q4
$207K Sell
2,305
-129
-5% -$12.2K ﹤0.01% 1234
2025
Q3
$240K Sell
2,434
-18
-0.7% -$1.78K ﹤0.01% 1064
2025
Q2
$224K Buy
2,452
+568
+30% +$54.9K 0.01% 958
2025
Q1
$213K Sell
1,884
-214
-10% -$22.9K 0.01% 944
2024
Q4
$229K Sell
2,098
-28
-1% -$3K 0.01% 916
2024
Q3
$230K Buy
+2,126
New +$232K 0.01% 886
2023
Q3
Sell
-1,592
Closed -$232K 826
2023
Q2
$232K Buy
+1,592
New +$216K 0.01% 693
2021
Q1
Sell
-416
Closed -$62K 1063
2020
Q4
$62K Buy
+416
New +$58.8K 0.01% 684
2018
Q2
Sell
-155
Closed -$16K 608
2018
Q1
$16K Hold
155
0.01% 470
2017
Q4
$18K Buy
155
+83
+115% +$9.39K 0.01% 424
2017
Q3
$8K Sell
72
-103
-59% -$11.9K ﹤0.01% 532
2017
Q2
$22K Hold
175
﹤0.01% 444
2017
Q1
$21K Hold
175
﹤0.01% 464
2016
Q4
$20K Hold
175
﹤0.01% 473
2016
Q3
$22K Buy
175
+72
+70% +$8.9K 0.01% 391
2016
Q2
$12K Hold
103
﹤0.01% 364
2016
Q1
$11K Buy
+103
New +$9.96K ﹤0.01% 238

Other funds holding ZBH

Perigon Wealth Management's ZBH Position: Q1 2026 in Review

Perigon Wealth Management increased its Zimmer Biomet (ZBH) stake by 32% in Q1 2026, buying an estimated $67.8K and bringing the position to 3,044 shares worth $275K. The position accounts for 0.01% of the portfolio, ranked #1056.

Perigon Wealth Management first reported a position in ZBH in Q1 2016 and has held it in 18 quarters since. 912 funds tracked by Wall St. Rank hold ZBH as of Q1 2026.

  • Perigon Wealth Management held 3,044 shares of Zimmer Biomet worth $275K as of Q1 2026.
  • Perigon Wealth Management bought 739 Zimmer Biomet shares in Q1 2026, an estimated $67.8K.
  • Zimmer Biomet made up 0.01% of Perigon Wealth Management's portfolio in Q1 2026, its #1056 holding.
  • Perigon Wealth Management first reported a position in Zimmer Biomet in Q1 2016 and has held it in 18 quarters since.
  • 912 funds tracked by Wall St. Rank held Zimmer Biomet as of Q1 2026.

Based on Perigon Wealth Management's 13F filing for Q1 2026, filed 10 Apr 2026.